Priscilla proposes a plan to trick Hunter into leaving the residence in a new episode of Tyler Perry's "The Oval" airing on Tuesday, Jan. 21.

Is Patrick Mahomes vs. Josh Allen already one of the great QB battles of NFL history? Josh Allen might need to win on Sunday to help cement its status.

Rep. Cody Harris had accused Abraham George of improperly threatening to send mailers and censure lawmakers who backed Rep.

Health-care companies rose after more promising data for the best-selling Glucagon-like Peptide inhibitor drugs. Shares of Novo Nordisk and Eli Lilly, the two leading producers of GLP-1 drugs, rallied ...

Here’s how Missouri football coach Eli Drinkwitz put together his final top 25 ballot in the final US LBM Coaches Poll.

Kyverna Therapeutics said it named Naji Gehchan as its chief medical and development officer. The clinical-stage biopharmaceutical company on Tuesday said that Gehchan comes from Eli Lilly, where he ...

A Boston real estate investment giant has spent more than $100 million for two very different properties on opposite sides of ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

Tonight’s episode of Tyler Perry’s “The Oval” is called “Grown Woman.” “The Oval” airs at 9 p.m. Tuesday, Jan. 21, on BET.

Viking (VKTX) is in the midst of a phase 2a dosing trial of its oral obesity drug VK2735, with a data readout expected in the second half of the year. The company is expected to launch a phase 3 trial ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...